I'll just start by indicating that we agree with the Auditor General's finding. We're working to put that in place and to have regular updates to the management table about the progress we're making.
Just to give you a little bit of context—and not to take away from the finding and our commitment to do better—I'll say that in the past, because of the size of the organization and for a variety of reasons, we have tried to target the focus of our training efforts and the scrutiny to those who are maybe in greater positions of influence, where the risk of fraud and the risk of values and ethics breaches are higher. For example, while the overall figure for our department is 20-something per cent, it's much higher for those who have signing authority and for managers. I don't have the figure immediately in front of me, but it's kind of in the 70%-or-higher range. We want to make sure that anybody who is in a position to make a managerial decision or to sign something for which funds are at stake.... That has typically been where we have tried to ensure that there is complete coverage.
The second thing is that, as a regulatory organization, we have a number of areas that present a higher risk because we have people making approval decisions on drugs or making regulatory decisions that affect industry. In those areas, we actually have specialized training and requirements for those employees, and the requirements are actually quite a bit higher than what they would be for a regular public servant.
All that is just to emphasize that we do take this very seriously. As an organization, we try to identify areas in which there's a particular risk because someone's dealing with a company, and they could be influenced. We have specialized requirements there. Then, for the management team, we insist on much greater adherence. It has been a challenge in the past. Given that we have a churn of at least 600 employees year, it has been a bit of a challenge to try to keep the training current. However, as I've noted, we certainly support the recommendation, and we're going to be working to try to follow up.